Skip to main content
Book cover

Clinical Trial Simulations

Applications and Trends

  • Book
  • © 2011

Overview

  • Includes updates, new uses and issues concerning CTS, along with case studies on how clinical trial simulations are being applied in various therapeutic and application areas Expands on the utility of CTS for informing decisions during drug development and regulatory review An information source that enables the reader to gain understanding of essential background and knowledge for practical applications of simulation for clinical trial design and analysis
  • Includes supplementary material: sn.pub/extras

Part of the book series: AAPS Advances in the Pharmaceutical Sciences Series (AAPS, volume 1)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 179.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 229.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (22 chapters)

  1. Application of M&S in Regulatory Decisions

  2. Clinical Trial Simulation and Quantitative Pharmacology

  3. Application of M&S in Regulatory Decisions

  4. Strategic Applications of M&S in Drug Development

  5. Application of M&S in Selected Therapeutic Areas

Keywords

About this book

This edition includes both updates and new uses and issues concerning CTS, along with case studies of how clinical trial simulations are being applied in various therapeutic and application areas. Importantly, the book expands on the utility of CTS for informing decisions during drug development and regulatory review. Each chapter author was selected on the basis of demonstrated expertise in state-of-the-art application of CTS. The target audience for this volume includes researchers and scientists who wish to consider use of simulations in the design, analysis, or regulatory review and guidance of clinical trials. This book does not embrace all aspects of trial design, nor is it intended as a complete recipe for using computers to design trials. Rather, it is an information source that enables the reader to gain understanding of essential background and knowledge for practical applications of simulation for clinical trial design and analysis. It is assumed that the reader has a working understanding of pharmacokinetics and pharmacodynamics, modeling, pharmacometric analyses, and/or the drug development and regulatory processes.

Reviews

From the reviews:

“‘Clinical Trial Simulations: Applications and Trends’ covers the evolving use of mathematical simulation models to supplement and sometimes even replace clinical trials. The book is primarily intended for clinical trialists and drug development and regulatory scientists.” (Norman M. Goldfarb, Journal of Clinical Research Best Practice, Vol. 8 (7), July, 2012)

Editors and Affiliations

  • Department of Advanced Modeling & Simula, Janssen Research & Development, LLC, Raritan, USA

    Holly H. C. Kimko

  • Dept. Biopharmaceutical Sciences, University of California, San Francisco, San Francisco, USA

    Carl C. Peck

About the editors

Holly H.C. Kimko, PhD is a senior pharmacometrics leader (Research Fellow) at the Department of Advanced Modeling & Simulation in Johnson & Johnson Pharmaceutical Research & Development, LLC, New Jersey, and Adjunct Professor in the faculty of the Pharmacy School of Rutgers University, New Jersey.  She was previously Assistant Professor in the Center for Drug Development Science in Georgetown University Medical School, Washington DC. Trained in biochemistry and pharmacy, Dr. Kimko earned her Ph.D. degree in Pharmaceutical Science from the State University of New York, Buffalo.  She has published key papers on indirect response modeling and applications of CTS, and co-edited Simulation for Designing Clinical Trials.

Carl C. Peck, MD is Adjunct Professor, Center for Drug Development Science in the Department of Bioengineering and Therapeutic Sciences, Schools of Pharmacy and Medicine, University of California San Francisco, California.  He was previously Director of the FDA Center for Drug Evaluation and Research, Assistant U.S. Surgeon General, and President of the American Society for Clinical Pharmacology and Therapeutics.  Dr. Peck has also held professorial appointments in the faculties of UCSF, USUHS, and Georgetown University.  He is an author of more than 150 original research papers, chapters and books concerning advanced concepts and techniques of quantitative pharmacology, trial designs, and pharmaco-statistical modeling and simulation.

Bibliographic Information

Publish with us